New treatments in Alzheimer's disease

被引:1
|
作者
Pickrell, William O. [1 ]
Robertson, Neil P. [2 ]
机构
[1] Swansea Univ, Med Sch, Neurol & Mol Neurosci, Swansea SA2 8PP, W Glam, Wales
[2] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Cardiff CF14 4XW, S Glam, Wales
基金
英国医学研究理事会;
关键词
Solanezumab; Prodromal Alzheimer; Brain Phospholipid Synthesis; Probable Mild Alzheimer; Disease Cooperative Study Activities;
D O I
10.1007/s00415-018-9018-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Alzheimer’s disease is the most common cause of dementia, affecting around 50 million people worldwide. Its prevalence is increasing mainly as a result of an ageing population with considerable associated increases in health and social care costs. As a result, government agencies worldwide have turned funding streams towards unravelling biological mechanisms and developing therapeutic opportunities for the dementias in general. Consequently, a number of novel potential treatments have been developed, although, to date, they have not been shown to significantly alter disease course. In this month’s journal club we look at three large clinical trials of new treatments in Alzheimer’s disease. © The Author(s) 2018.
引用
收藏
页码:2162 / 2162
页数:1
相关论文
共 50 条
  • [31] Disease-modifying treatments in Alzheimer's disease
    Edwards, Marc
    Corkill, Robin
    JOURNAL OF NEUROLOGY, 2023, 270 (04) : 2342 - 2344
  • [32] Aducanumab and disease modifying treatments for Alzheimer's disease
    Thomas, Emily
    Wasunna-Smith, Brenda
    Kuruvilla, Tarun
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2021, 25 (03) : 4 - 6
  • [33] Guidelines on drug treatments for Alzheimer's disease
    Lovestone, S
    Graham, N
    Howard, R
    LANCET, 1997, 350 (9073): : 232 - 233
  • [34] Possible alternative treatments of Alzheimer's disease
    Robertson, DS
    MEDICAL HYPOTHESES, 2004, 63 (06) : 1083 - 1084
  • [35] CURRENT AND FUTURE TREATMENTS FOR ALZHEIMER'S DISEASE
    Salloway, Stephen
    CNS SPECTRUMS, 2009, 14 (08) : 4 - 7
  • [36] Posterior cortical atrophy: new insights into treatments and biomarkers for Alzheimer's disease
    Bejanin, Alexandre
    Villain, Nicolas
    LANCET NEUROLOGY, 2024, 23 (02): : 127 - 128
  • [37] Current and future treatments for Alzheimer's disease
    Yiannopoulou, Konstantina G.
    Papageorgiou, Sokratis G.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2013, 6 (01) : 19 - 33
  • [38] Compliance of two treatments of Alzheimer's disease
    Barbeau, M
    Baladi, JF
    VALUE IN HEALTH, 2002, 5 (06) : 513 - 513
  • [39] New pharmacological treatments for Alzheimer's disease: implications for dementia care nursing
    Adams, T
    Page, S
    JOURNAL OF ADVANCED NURSING, 2000, 31 (05) : 1183 - 1188
  • [40] Current and Future Treatments in Alzheimer's Disease
    Atri, Alireza
    SEMINARS IN NEUROLOGY, 2019, 39 (02) : 227 - 240